GILAD OREN (President) received a stock award from APREA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/16/2026ACC: 0001104659-26-028656
DirectorOfficer· President
Since May 2022
+100.88K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
100.88K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20.18K
Price / share
—
Trade value
—
% of position
5.4%
3/12/2026
373.72K→393.89K
Total
Net shares
+20.18K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/12/2026 | A · Award | +20.18K | — | — | 5.4% | 373.72K | 393.89K |
| Total | +20.18K | $0.00 | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
80.70K shares
Shares
+80.70K
Strike price
0.765
Held after
80.70K
Exercisable
—
3/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock80.70K shares | 3/12/2026 | A · Award | +80.70K | 0.765 | — | 80.70K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.20K
Common Stock
IndirectShares owned600.00
Total
1.80K indirect1.80K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.20K | Indirect |
| Common Stock | 600.00 | Indirect |
| Total | 1.80K | 1.80K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported